Drug Eluting Balloons (DEBs)

Drug Eluting Balloons (DEBs)

Global Drug Eluting Balloons (DEBs) Market to Reach $3 Billion by 2030
The global market for Drug Eluting Balloons (DEBs) estimated at US$1.4 Billion in the year 2023, is expected to reach US$3 Billion by 2030, growing at a CAGR of 9.9% over the period 2023-2030. Peripheral Drug Eluting Balloons, one of the segments analyzed in the report, is expected to record 8.1% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Coronary Drug Eluting Balloons segment is estimated at 12.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $433.5 Million, While China is Forecast to Grow at 9.5% CAGR
The Drug Eluting Balloons (DEBs) market in the U.S. is estimated at US$433.5 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$534.7 Million by the year 2030 trailing a CAGR of 9.5% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 8.4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Introducing Our Exciting New Report Features for 2024
» Full access to influencer engagement stats
» Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
» Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
» Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
» Complimentary report updates for one year
» Competitor coverage with global market shares of major players
» Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
» Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 42 Featured) -
  • Acrostak Int. Distr. Sarl
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Cardionovum GmbH
  • Cook Medical, Inc.
  • Eurocor GmbH
  • Medtronic PLC
  • Spectranetics Corporation
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Drug Eluting Balloons (DEBs) – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Incidence of Cardiovascular Diseases Drives Demand for Drug Eluting Balloons (DEBs)
Increasing Focus on Minimally Invasive Procedures Strengthens Business Case for Drug Eluting Balloons
Expansion of Peripheral Artery Disease (PAD) Treatment Spurs Demand for DEBs in Vascular Interventions
Technological Innovations in Biodegradable Polymers Set the Stage for Market Growth in Drug Eluting Balloons
Rising Adoption of DEBs in Coronary Artery Disease (CAD) Treatment Expands Market Opportunities
Increasing Use of DEBs in Renal and Carotid Artery Interventions Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Drug Eluting Balloons (DEBs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Drug Eluting Balloons (DEBs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Cath Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Drug Eluting Balloons (DEBs) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 14: World Recent Past, Current & Future Analysis for Peripheral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Peripheral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Peripheral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Coronary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 21: USA Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: USA 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 23: USA Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
CANADA
TABLE 26: Canada Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: Canada 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 29: Canada Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
JAPAN
Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 32: Japan Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Japan 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 35: Japan Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
CHINA
Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 38: China Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: China Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: China 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 41: China Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
EUROPE
Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 44: Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Drug Eluting Balloons (DEBs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
FRANCE
Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 53: France Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: France Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: France 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
GERMANY
Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 59: Germany Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Germany 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
ITALY
TABLE 65: Italy Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Italy 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
UNITED KINGDOM
Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 71: UK Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: UK Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: UK 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Rest of Europe Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Rest of Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Rest of Europe Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Rest of Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Asia-Pacific Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Asia-Pacific 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Asia-Pacific Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Asia-Pacific 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 89: Rest of World Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Rest of World Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Rest of World 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
TABLE 92: Rest of World Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of World Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of World 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings